MR Biophysics Lab

Buffalo Neuroimaging Analysis Center

Baseline Cognition and Imaging Measures of Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Study of the Effect of Ozanimod on Cognitive Processing Speed.

Conference paper

DeLuca J, Riolo JV, Cheng C, Naismith RT, Wray S, Bass A, Fox E, Riser E, Chaudhry B, Silva D, Zivadinov R
Americas Committee for Treatment and Research in Multiple Sclerosis Forum, San Diego, CA, 2023
Cite

Cite

APA
J, D. L., JV, R., C, C., RT, N., S, W., A, B., … R, Z. (2023). Baseline Cognition and Imaging Measures of Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Study of the Effect of Ozanimod on Cognitive Processing Speed. San Diego, CA.

Chicago/Turabian
J, DeLuca, Riolo JV, Cheng C, Naismith RT, Wray S, Bass A, Fox E, et al. “Baseline Cognition and Imaging Measures of Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Study of the Effect of Ozanimod on Cognitive Processing Speed.” Americas Committee for Treatment and Research in Multiple Sclerosis Forum. San Diego, CA, 2023.

MLA
J, DeLuca, et al. Baseline Cognition and Imaging Measures of Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Study of the Effect of Ozanimod on Cognitive Processing Speed. 2023.